Evidence map›Paper›PMID 39168127›Full record

ArticleCell metabolism2024

Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females.

Brendan Cordeiro, Jeeyoon Jennifer Ahn, Saurabh Gawde, Carmen Ucciferri, Nuria Alvarez-Sanchez, Xavier S Revelo, Natalie Stickle, Kaylea Massey, David G Brooks, Joel M Guthridge and 4 more

Abstract read
In one paragraph

Article in Cell metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. T cell dysregulation and remodeling in pediatric obesity and weight loss.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Frontiers in immunology · 2025
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Brendan CordeiroKeenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.
Jeeyoon Jennifer AhnDepartment of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Saurabh GawdeArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA; Department of Microbiology and Immunology, Oklahoma University Health Science Center, Oklahoma City, OK 73104, USA.
Carmen UcciferriDepartment of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Nuria Alvarez-SanchezKeenan Research Centre for Biomedical Science of St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.
Xavier S ReveloDepartment of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN 55455, USA.
Natalie StickleBioinformatics and High Performance Computing Core, University Health Network, Toronto, ON M5G 1L7, Canada.
Kaylea MasseyArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
David G BrooksDepartment of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada.
Joel M GuthridgeArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Gabriel PardoArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA; Multiple Sclerosis Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Daniel A WinerDepartment of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada; Buck Institute for Research on Aging, Novato, CA 94945, USA; Division of Cellular and Molecular Biology, Diabetes Research Group, Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, ON M5S 1A8, Canada.
Robert C AxtellArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA; Department of Microbiology and Immunology, Oklahoma University Health Science Center, Oklahoma City, OK 73104, USA. Electronic address: bob-axtell@omrf.org.
Shannon E DunnDepartment of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada; Women's College Research Institute, Women's College Hospital, Toronto, ON M5G 1N8, Canada; Sunnybrook Research Institute, Sunnybrook Hospital, Toronto, ON M4M 3M5, Canada. Electronic address: shannon.dunn@utoronto.ca.

Funding

Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.R01AI137047 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C · 2018 to 2021
$2.8M
Pathogenic B cell and T helper cell interactions in Neuromyelitis OpticaR01EY027346 · NEI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C · 2017 to 2021
$2.2M
NEI NIH HHS R01 EY027346NIAID NIH HHS R01 AI137047
6 · The paper itself

Abstract

Obesity has been implicated in the rise of autoimmunity in women. We report that obesity induces a serum protein signature that is associated with T helper 1 (Th1), interleukin (IL)-17, and multiple sclerosis (MS) signaling pathways selectively in human females. Females, but not male mice, subjected to diet-induced overweightness/obesity (DIO) exhibited upregulated Th1/IL-17 inflammation in the central nervous system during experimental autoimmune encephalomyelitis, a model of MS. This was associated with worsened disability and a heightened expansion of myelin-specific Th1 cells in the peripheral lymphoid organs. Moreover, at steady state, DIO increased serum levels of interferon (IFN)-α and potentiated STAT1 expression and IFN-γ production by naive CD4

Indexed as

AutoimmunityCentral Nervous SystemEncephalomyelitis, Autoimmune, ExperimentalMice, Inbred C57BLObesitySignal TransductionAnimalsFemaleHumansInterleukin-17MaleMiceMultiple SclerosisSex CharacteristicsSex FactorsSTAT1 Transcription FactorInterleukin-17STAT1 Transcription Factorautoimmunityexperimental autoimmune encephalomyelitisinterferon-αmultiple sclerosisobesitysex differencesT cellsT helper 1 differentiation

Identifiers

PMID39168127
PMCPMC11463735

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.